Bluejay Diagnostics (BJDX) Other Non Operating Income (2020 - 2026)
Bluejay Diagnostics recorded quarterly Other Non Operating Income of $731.0 in Q1 2026, up 26.25% quarter-over-quarter from $579.0 in Q4 2025, and down 89.06% year-over-year from $6681.0 in Q1 2025.
Bluejay Diagnostics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $731.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 89.06% year-over-year to $731.0; the TTM figure through Mar 2026 stood at $1589.0 (down 97.39% YoY), while the FY2025 annual figure was $7769.0, down 93.98% from the prior year.
- Other Non Operating Income came in at $731.0 for Q1 2026 at Bluejay Diagnostics, up from $579.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $139729.0 in Q1 2023 to a low of -$80918.0 in Q4 2023.
- A 5-year average of $25986.1 and a median of $8566.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 1759.18% in 2023 and jumped 118.23% in 2024, its largest moves.
- Bluejay Diagnostics' Other Non Operating Income stood at $4877.0 in 2022, then plunged by 1759.18% to -$80918.0 in 2023, then surged by 118.23% to $14751.0 in 2024, then plunged by 96.07% to $579.0 in 2025, then gained by 26.25% to $731.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $731.0, $579.0, and $554.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731.00 |
| Dec 31, 2025 | 579.00 |
| Sep 30, 2025 | 554.00 |
| Jun 30, 2025 | -275.00 |
| Mar 31, 2025 | 6,681.00 |
| Dec 31, 2024 | 14,751.00 |
| Sep 30, 2024 | 8,566.00 |
| Jun 30, 2024 | 30,944.00 |
| Mar 31, 2024 | 69,549.00 |
| Dec 31, 2023 | -80,918.00 |
| Sep 30, 2023 | 43,235.00 |
| Jun 30, 2023 | 90,383.00 |
| Mar 31, 2023 | 139,729.00 |
| Dec 31, 2022 | 4,877.00 |
| Sep 30, 2022 | 60,406.00 |
| Mar 31, 2021 | 6,111.00 |
| Dec 31, 2020 | 2,889.00 |
| Sep 30, 2020 | 4,344.00 |